California ophthalmology & optometry billing: Medi-Cal, IPAs and the 2027 rules.
California operates 4,938 optometry / ophthalmology provider organizations registered in NPPES, representing 10.3 percent of the U.S. optometry / ophthalmology billing footprint. California is one of the largest optometry / ophthalmology billing market. Eye care revenue cycle blends ophthalmology vs medical E/M decisions, refraction vs medical separation, cataract surgery and IOL billing, diagnostic imaging, and Medicare vision benefit complexity. California eye care practices need RCM with specialty depth.
What good optometry / ophthalmology billing execution looks like for California providers.
The California optometry / ophthalmology billing market has its own quirks. Here is the operating discipline we install on every California engagement.
- Comprehensive eye exam vs E/M decisionEye care providers choose between ophthalmology E/M codes (92002-92014) and medical E/M codes (99202-99215) per visit. California practices need rules for when to use which.
- Refraction billing vs medical billing separationRefraction (92015) is typically not covered by medical insurance. California practices need clean separation between covered medical eye care and self-pay refraction services.
- Cataract surgery + IOL billingCataract surgery (66984) plus IOL device billing (V2632 for standard, premium IOL upgrade for patient self-pay) requires accurate facility/professional split and patient responsibility tracking.
- Diagnostic imaging (OCT, fundus photo) billingOCT (92133, 92134), fundus photography (92250), and visual field testing (92083) carry distinct codes with frequency limits and medical necessity criteria.
- Glaucoma + retina specialty codingGlaucoma SLT (65855), iStent (0191T), and retina anti-VEGF injections (67028 + J-codes) require specialty coding depth.
- Medicare vision benefit limitationsMedicare typically covers medical eye care but not routine vision (refraction, eyeglasses). California practices need to set patient expectations and bill correctly.
The California rulebook
Seven rules that decide when California eye claims get paid.
Federal Medicare rules set the codes. California sets the clocks, the interest and who owes the claim when an IPA holds the risk. Each rule links to its source.
- 30-day payment clockKnox-Keene plans and the IPAs that pay for them must pay, contest or deny a complete claim within 30 calendar days, for claims received from 1 Jan 2026 (AB 3275).Source: DMHC, APL 25-007
- Interest is owed automaticallyA late complete claim earns 15% a year from day 31. A payer that leaves it off owes the greater of $15 or 10% of the interest.Source: DMHC, APL 25-007
- 90 days to correct a claimFrom 1 Jan 2027, SB 1049 gives at least 90 calendar days to file a corrected claim after a denial or overpayment notice for a fixable defect.Source: California Legislature, SB 1049
- Eyelid surgery in the ASC needs prior authCalifornia is in the CMS ASC prior authorization demonstration for blepharoplasty, for dates of service from 19 Jan 2026.Source: CMS, ASC prior authorization demonstration
- Noridian wants the eye on every MIGS claimSince 1 Jun 2026 Noridian JE article A57863 requires RT, LT or 50 on micro-invasive glaucoma surgery claims.Source: CMS Coverage Database, A57863
- Medi-Cal routine examsA routine comprehensive eye exam is covered once every two years at any age, by an ophthalmologist or optometrist, and more often when medically necessary.Source: DHCS, Medi-Cal vision benefits
- Medicare Advantage appealsA Medicare Advantage reconsideration is due within 65 days of the denial notice, per CMS. Track it by plan, not by IPA.Source: CMS, MA reconsideration
Verified changes, January 2026 to June 2027
What changed for California eye care.
From the Eye Care Payer Policy Matrix. Every item was read at its primary source.
- 2026-01-01California AB 3275 (Health and Safety Code 1371) now requires Knox-Keene plans, including specialized plans, to pay complete claims within 30 calendar days of receipt, operative 1 Jan 2026. Late eye claims (cataract, retina injections, OCT) carry interest and penalties.Source: leginfo.legislature.ca.gov
- 2026-01-01Blue Shield of California Medicare Advantage plans (PPO, 65 Plus HMOs, TotalDual D-SNP and others) require Part B prior authorization in 2026 for anti-VEGF drugs: aflibercept (Eylea, Eylea HD, Pavblu), bevacizumab products, Vabysmo and ranibizumab products including Cimerli, Nufymco and Byooviz.Source: blueshieldca.com
- 2026-01-19CMS ASC prior authorization demonstration started in California for dates of service on or after 19 Jan 2026 (requests from 5 Jan 2026). ASC blepharoplasty and related eyelid procedures need a prior authorization request or face prepayment review.Source: cms.gov
- 2026-06-01Noridian JE billing article A57863 (MIGS), revised effective 1 Jun 2026, now requires RT, LT or 50 on every micro-invasive glaucoma surgery claim to show which eye was treated.Source: cms.gov
- 2026-07-01DHCS Prop 35 Primary and Specialty Care supplemental payments for Medi-Cal FFS and managed care network providers cover dates of service 1 Jul to 31 Dec 2026, pending federal approval of SPA 26-0029.Source: dhcs.ca.gov
- 2026-09-01Blue Shield of California Promise (Medi-Cal managed care) ranibizumab policy, effective 1 Sep 2026, names Nufymco (Q5168) and Cimerli as preferred ranibizumab products. Lucentis now needs an intolerance or contraindication to the preferred biosimilars.Source: blueshieldca.com
- 2027-01-01California SB 1049 (signed 30 Sep 2026, effective 1 Jan 2027) gives providers at least 90 calendar days to file a corrected claim after a plan or insurer denies a claim or sends an overpayment notice for a fixable defect, such as a missing eye modifier or NDC.Source: leginfo.legislature.ca.gov
Medicare in California
Noridian Healthcare Solutions, jurisdiction JE: the eye LCDs that apply.
Medicare Advantage plans must follow these coverage rules too, so they reach far beyond Original Medicare claims. The 2027 changes for every eye code are in our 2027 fee schedule guide for eye care.
- A53008 Billing and Coding: Intraocular Bevacizumab
- L34194 Blepharoplasty, Eyelid Surgery, and Brow Lift
- A57190 Billing and Coding: Blepharoplasty, Eyelid Surgery, and Brow Lift
- L34203 Cataract Surgery in Adults
- A57195 Billing and Coding: Cataract Surgery in Adults
- L38299 Micro-Invasive Glaucoma Surgery (MIGS)
- A57863 Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
FAQ: optometry / ophthalmology billing in California.
How many optometry / ophthalmology providers operate in California?
NPPES lists 4,938 optometry / ophthalmology provider organizations in California, representing 10.3% of the U.S. footprint. Top concentrations are in Los Angeles (221), San Diego (185), San Jose (119).
Does Medi-Cal cover optometry / ophthalmology billing services?
Yes. Medi-Cal covers optometry / ophthalmology billing services for eligible beneficiaries, with plan-specific authorization rules and rate structures that vary by year.
What commercial payers cover optometry / ophthalmology billing in California?
All major national commercial payers cover optometry / ophthalmology billing in California, including UnitedHealthcare/Optum, Aetna, Cigna/Evernorth, the dominant California Blue Cross Blue Shield plan, and (where active) Humana.
Does ASP-RCM serve optometry / ophthalmology providers in California?
Yes. ASP-RCM Solutions provides optometry and ophthalmology billing services for providers in California and across all 50 states. Senior partners on every account. Request a free RCM audit.
How do I get started?
Request a free RCM audit. We assess your current state, identify revenue leakage, and produce a written prioritized recommendations list.
See where your eye care revenue is leaking.
A senior partner reviews your retina drug lines, surgery and ASC claims, prior authorizations and AR against the 2027 rules on this page, and hands you the leak map. 30 minutes, no obligation, no sales rep.
Get your free audit
30 minutes. Your eye care denials, drug lines and AR, and the leak map we see. No obligation.